Perkinelmer Stock Fundamentals
| PKIDelisted Stock | USD 115.24 0.74 0.64% |
PerkinElmer fundamentals help investors to digest information that contributes to PerkinElmer's financial success or failures. It also enables traders to predict the movement of PerkinElmer Stock. The fundamental analysis module provides a way to measure PerkinElmer's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PerkinElmer stock.
PerkinElmer |
PerkinElmer Company Return On Equity Analysis
PerkinElmer's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current PerkinElmer Return On Equity | 0.0706 |
Most of PerkinElmer's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PerkinElmer is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, PerkinElmer has a Return On Equity of 0.0706. This is 100.29% lower than that of the Life Sciences Tools & Services sector and 101.06% lower than that of the Health Care industry. The return on equity for all United States stocks is 122.77% lower than that of the firm.
PerkinElmer Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining PerkinElmer's current stock value. Our valuation model uses many indicators to compare PerkinElmer value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PerkinElmer competition to find correlations between indicators driving PerkinElmer's intrinsic value. More Info.PerkinElmer is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.52 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for PerkinElmer is roughly 1.91 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PerkinElmer's earnings, one of the primary drivers of an investment's value.PerkinElmer Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PerkinElmer's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PerkinElmer could also be used in its relative valuation, which is a method of valuing PerkinElmer by comparing valuation metrics of similar companies.PerkinElmer is currently under evaluation in return on equity category among its peers.
PerkinElmer Fundamentals
| Return On Equity | 0.0706 | |||
| Return On Asset | 0.0369 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 22.3 B | |||
| Shares Outstanding | 126.41 M | |||
| Shares Owned By Insiders | 0.26 % | |||
| Shares Owned By Institutions | 86.25 % | |||
| Number Of Shares Shorted | 3.53 M | |||
| Price To Earning | 21.07 X | |||
| Price To Book | 2.57 X | |||
| Price To Sales | 3.68 X | |||
| Revenue | 3.31 B | |||
| Gross Profit | 2.04 B | |||
| EBITDA | 1.2 B | |||
| Net Income | 579.18 M | |||
| Cash And Equivalents | 454.36 M | |||
| Cash Per Share | 2.86 X | |||
| Total Debt | 3.92 B | |||
| Debt To Equity | 0.65 % | |||
| Current Ratio | 2.02 X | |||
| Book Value Per Share | 58.45 X | |||
| Cash Flow From Operations | 679.81 M | |||
| Short Ratio | 5.07 X | |||
| Earnings Per Share | 4.06 X | |||
| Price To Earnings To Growth | 4.02 X | |||
| Target Price | 151.93 | |||
| Number Of Employees | 16.7 K | |||
| Beta | 1.1 | |||
| Market Capitalization | 15.74 B | |||
| Total Asset | 14.13 B | |||
| Retained Earnings | 4.95 B | |||
| Working Capital | 1.73 B | |||
| Current Asset | 988.01 M | |||
| Current Liabilities | 684.07 M | |||
| Z Score | 3.56 | |||
| Annual Yield | 0 % | |||
| Five Year Return | 0.27 % | |||
| Net Asset | 14.13 B | |||
| Last Dividend Paid | 0.28 |
About PerkinElmer Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PerkinElmer's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PerkinElmer using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PerkinElmer based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts. Perkinelmer operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 16000 people.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in PerkinElmer Stock
If you are still planning to invest in PerkinElmer check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PerkinElmer's history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |